Literature DB >> 12569093

Functional interaction between the c-Abl and Arg protein-tyrosine kinases in the oxidative stress response.

Cheng Cao1, Yumei Leng, Chufang Li, Donald Kufe.   

Abstract

The Abl family of mammalian nonreceptor tyrosine kinases consists of c-Abl and Arg. Recent work has shown that c-Abl and Arg are activated in the cellular response to oxidative stress. The present studies demonstrate that reactive oxygen species (ROS) induce the formation of c-Abl and Arg heterodimers. The results show that the c-Abl SH3 domain binds directly to a proline-rich site (amino acids 567-576) in the Arg C-terminal region. Formation of c-Abl.Arg heterodimers also involves direct binding of the Arg Src homology 3 domain to the C-terminal region of c-Abl. The results further demonstrate that the interaction between c-Abl and Arg involves c-Abl-mediated phosphorylation of Arg. The functional significance of the c-Abl-Arg interaction is supported by the demonstration that both c-Abl and Arg are required for ROS-induced apoptosis. These findings indicate that ROS induce c-Abl.Arg heterodimers and that both c-Abl and Arg are necessary as effectors in the apoptotic response to oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12569093     DOI: 10.1074/jbc.M300058200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Tau phosphorylated at tyrosine 394 is found in Alzheimer's disease tangles and can be a product of the Abl-related kinase, Arg.

Authors:  Matthew A Tremblay; Christopher M Acker; Peter Davies
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  Protein kinase G increases antioxidant function in lung microvascular endothelial cells by inhibiting the c-Abl tyrosine kinase.

Authors:  R Scott Stephens; Laura E Servinsky; Otgonchimeg Rentsendorj; Todd M Kolb; Alexander Pfeifer; David B Pearse
Journal:  Am J Physiol Cell Physiol       Date:  2014-01-08       Impact factor: 4.249

3.  Neuronal c-Abl overexpression leads to neuronal loss and neuroinflammation in the mouse forebrain.

Authors:  Sarah D Schlatterer; Matthew A Tremblay; Christopher M Acker; Peter Davies
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

4.  c-Abl-p38α signaling plays an important role in MPTP-induced neuronal death.

Authors:  R Wu; H Chen; J Ma; Q He; Q Huang; Q Liu; M Li; Z Yuan
Journal:  Cell Death Differ       Date:  2015-10-30       Impact factor: 15.828

5.  Impaired Peroxisomal Fitness in Obese Mice, a Vicious Cycle Exacerbating Adipocyte Dysfunction via Oxidative Stress.

Authors:  Lingjuan Piao; Debra Dorotea; Songling Jiang; Eun Hee Koh; Goo Taeg Oh; Hunjoo Ha
Journal:  Antioxid Redox Signal       Date:  2019-12-20       Impact factor: 8.401

Review 6.  Targeting Abl kinases to regulate vascular leak during sepsis and acute respiratory distress syndrome.

Authors:  Alicia N Rizzo; Jurjan Aman; Geerten P van Nieuw Amerongen; Steven M Dudek
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03-26       Impact factor: 8.311

Review 7.  ABL tyrosine kinases: evolution of function, regulation, and specificity.

Authors:  John Colicelli
Journal:  Sci Signal       Date:  2010-09-14       Impact factor: 8.192

Review 8.  Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities.

Authors:  Edith Lubos; Joseph Loscalzo; Diane E Handy
Journal:  Antioxid Redox Signal       Date:  2011-04-10       Impact factor: 8.401

9.  Redox regulation of antioxidant enzymes: post-translational modulation of catalase and glutathione peroxidase activity by resveratrol in diabetic rat liver.

Authors:  Gökhan Sadi; Davut Bozan; Huseyin Bekir Yildiz
Journal:  Mol Cell Biochem       Date:  2014-04-17       Impact factor: 3.396

Review 10.  Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart.

Authors:  Alexander T Akhmedov; Vitalyi Rybin; José Marín-García
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.